Mineral Metabolism in Chronic Kidney Disease

Displaying 1 - 41 of 41CSV
Fontana, M., Gillmore, J. D., Witteles, R. M., Laryea, B., Dworkin, M., Payne, A., Kochman, F., Eraly, S., & Maurer, M. S. (2025). Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary. Future Cardiology, 1–11. https://doi.org/10.1080/14796678.2025.2493019
Publication Date
Masri, A., Aras, M., Grogan, M., Jacoby, D., Maurer, M. S., Shah, S. J., Witteles, R., Wong, P. W., Ji, A. X., Du, J., Siddhanti, S., Katz, L., Sinha, U., Fox, J. C., & Judge, D. P. (2025). Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.03.017
Publication Date
Maurer, M. S., Witteles, R. M., Garcia-Pavia, P., Sheikh, F. H., Morbach, C., Rodriguez Duque, D., Aldinc, E., Eraly, S. A., & Gillmore, J. D. (2025). Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin Amyloidosis with Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2025.03.477
Publication Date
Judge, D. P., Alexander, K. M., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S. D. J., Grogan, M., Hanna, M., Masri, A., Maurer, M. S., Obici, L., Soman, P., Cao, X., Lystig, T., Tamby, J.-F., Siddhanti, S., Castaño, A., Katz, L., Fox, J. C., … Gillmore, J. D. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology, 85(10), 1003–1014. https://doi.org/10.1016/j.jacc.2024.11.042
Publication Date
Hsu, S. Y., Kuo, E. J., McManus, C., Liou, R., Lee, J. A., & Kuo, J. H. (2025). Utility of Parathyroid Autofluorescence in Differentiating Parathyroid Pathology. World Journal of Surgery. Portico. https://doi.org/10.1002/wjs.12524
Publication Date
Song, A., Mellgard, G., Bellofiore, C., Basset, M., Nuvolone, M., Foli, A., Merlini, G., Maurer, M. S., Mapara, M. Y., Bhutani, D., Lentzsch, S., Shaish, H., Palladini, G., Chakraborty, R., & Milani, P. (2025). Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study. Blood Advances. https://doi.org/10.1182/bloodadvances.2024015646
Publication Date
Henner, D. E., Drambarean, B., Gerbeling, T. M., Kendrick, J. B., Kendrick, W. T., Koester-Wiedemann, L., Nickolas, T. L., Rastogi, A., Rauf, A. A., Dyson, B., Singer, M. C., Desai, P., Fox, K. M., Cheng, S., & Goodman, W. (2025). Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel. PLOS ONE, 20(1), e0266281. https://doi.org/10.1371/journal.pone.0266281
Publication Date
Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Jay, P. Y., & Solomon, S. D. (2025). Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.10.097
Publication Date
Lyons, G., Thompson, J., Lousada, I., Catini, J., Manwani, R., & Maurer, M. S. (2025). Diagnostic pathways, cardiac manifestations and outcomes in light chain amyloidosis: analysis of a US claims database. Open Heart, 12(1), e003124. https://doi.org/10.1136/openhrt-2024-003124
Publication Date
Columbia Affiliation
Castellano, T., Wang, T. C., Nolan, E., Archer, D. B., Cody, K., Harrison, T. M., Wu, Y., Durant, A., Janve, V. A., Engelman, C. D., Jagust, W. J., Albert, M. S., Johnson, S. C., Resnick, S. M., Sperling, R. A., Bilgel, M., Saykin, A. J., Vardarajan, B. N., Mayeux, R., … Koran, M. E. I. (2024). Genetic and Sex Associations with Earlier Estimated Onset of Amyloid Positivity from over 4000 Harmonized Positron Emission Tomography Images. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092852
Publication Date
Folkvaljon, F., Gertz, M., Gillmore, J. D., Khella, S., Masri, A., Maurer, M. S., Cruz, M. W., Wixner, J., Chen, J., Reicher, B., Kwoh, J., Yarlas, A., & Berk, J. L. (2024). Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health‐Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis. Muscle & Nerve, 71(1), 96–107. Portico. https://doi.org/10.1002/mus.28299
Publication Date
Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Aldinc, E., Eraly, S. A., Jay, P. Y., & Solomon, S. D. (2024). Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.11.015
Publication Date
Tian, L., Jaeger, B. C., Scialla, J. J., Budoff, M. J., Mehta, R. C., Jaar, B. G., Saab, G., Dobre, M. A., Reilly, M. P., Rader, D. J., Townsend, R. R., Lash, J. P., Greenland, P., Isakova, T., Bundy, J. D., Anderson, A. H., Appel, L. J., Chen, J., Cohen, D., … Unruh, M. L. (2024). Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2024.06.018
Publication Date
Bruce, S. L., Cuomo, M., Yarmohammadi, H., Wan, E. Y., Saluja, D., Sciacca, R., Garan, H., Griffin, J. M., Maurer, M. S., & Biviano, A. B. (2024). Monitoring for arrhythmia in transthyretin cardiac amyloidosis with noninvasive ambulatory patch devices. Heart Rhythm O2. https://doi.org/10.1016/j.hroo.2024.07.013
Publication Date
Rubin, M. R., Cusano, N., Yin, S., Tokareva, E., Ayodele, O., & Finkelman, R. D. (2024). Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism. Endocrine Practice, 30(3), 200–208. https://doi.org/10.1016/j.eprac.2023.12.001
Publication Date
Muchtar, E., Palladini, G., Schonland, S., Dispenzieri, A., Wisniowski, B., Merlini, G., Milani, P., Hegenbart, U., Dittrich, T., Kastritis, E., Dimopoulos, M. A., Sanchorawala, V., Szalat, R. E., Liedtke, M., Gupta, M., Landau, H., Lentzsch, S., Hughes, M. S., Cibeira López, M. T., … Gertz, M. A. (2023). Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study. Blood, 142(Supplement 1), 3411–3411. https://doi.org/10.1182/blood-2023-190226
Publication Date
Wuni, G., Teruya, S., Ionescu, N., Janvier, I., Helmke, S., Fine, D., Ruberg, F., Raiszadeh, F., Kurian, D., Maurer, M., & Vaishnava, P. (2023). Prevalence, adequacy and adherence of anticoagulation for stroke thromboprophylaxis in minority patients with atrial fib referred for transthyretin cardiac amyloidosis screening: The SCAN-MP Study. European Heart Journal, 44(Supplement_2). https://doi.org/10.1093/eurheartj/ehad655.2092
Publication Date
Gordon, E. R., Trager, M. H., Adeuyan, O., Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Husain, S., Coromilas, A. J., & Geskin, L. J. (2023). Alone on a collagen island: Unique findings of osseous sclerotic bodies in nephrogenic systemic fibrosis. JAAD Case Reports, 40, 117–119. https://doi.org/10.1016/j.jdcr.2023.08.010
Publication Date
Martinez-Calle, M., Courbon, G., Hunt-Tobey, B., Francis, C., Spindler, J., Wang, X., dos Reis, L. M., Martins, C. S. W., Salusky, I. B., Malluche, H., Nickolas, T. L., Moyses, R. M. A., Martin, A., & David, V. (2023). Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy. Journal of Clinical Investigation, 133(11). https://doi.org/10.1172/jci159928
Publication Date
Chan, N., Teruya, S. L., Mirabal, A., Santos, J. D. L., Guadalupe, S., Rodriguez, C., Helmke, S., Cuomo, M., Smiley, D., & Maurer, M. S. (2023). OUTCOMES OF PATIENTS DIAGNOSED WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS: ENDOMYOCARDIAL BIOPSY VERSUS NUCLEAR SCINTIGRAPHY. Journal of the American College of Cardiology, 81(8), 543. https://doi.org/10.1016/s0735-1097(23)00987-7
Publication Date
Rosenblum, H., Gundapaneni, B., Lopez-Charneco, M., Sultan, M., Burkhoff, D., & Maurer, M. S. (2023). TAFAMIDIS DELAYS PROGRESSION OF CARDIAC DYSFUNCTION IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS: NON-INVASIVE PRESSURE VOLUME ANALYSIS OF THE ATTR-ACT TRIAL. Journal of the American College of Cardiology, 81(8), 341. https://doi.org/10.1016/s0735-1097(23)00785-4
Publication Date
Chung, A., Driggin, E., Clerkin, K. J., Teruya, S. L., Santos, J. D. L., & Maurer, M. S. (2023). VARIABILITY IN ESTIMATED GLOMERULAR FILTRATION RATE WITH CYSTATIN C VS CREATININE IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS (ATTR-CA). Journal of the American College of Cardiology, 81(8), 619. https://doi.org/10.1016/s0735-1097(23)01063-x
Publication Date
Garcia Pavia, P., Gillmore, J. D., Kale, P., Berk, J. L., Maurer, M. S., Conceição, I., Dicarli, M., Solomon, S., Chen, C., Arum, S., Vest, J., Grogan, M., & Hababou, C. (2023). HELIOS-A: 18-month exploratory cardiac results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis. Archives of Cardiovascular Diseases Supplements, 15(1), 31–32. https://doi.org/10.1016/j.acvdsp.2022.10.056
Publication Date
Cuddy, S. A., Datar, Y., Ovsak, G., Saith, S., Murphy, S. P., Bay, C. P., Haddad, M., Lilleness, B., Muralidhar, V., Pipilas, A., Vuong, J., Guardino, E., Maurer, M. S., Ruberg, F. L., Falk, R. H., & Dorbala, S. (2022). Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Circulation: Cardiovascular Imaging, 15(11). https://doi.org/10.1161/circimaging.122.014645
Publication Date
Gonzalez-Lopez, E., Escobar-Lopez, L., Obici, L., Saturi, G., Bezard, M., Saith, S. E., AbouEzzeddine, O. F., Mussinelli, R., Gagliardi, C., Kharoubi, M., Griffin, J. M., Dispenzieri, A., Vilches, S., Perlini, S., Longhi, S., Oghina, S., Rivas, A., Grogan, M., Maurer, M. S., … Garcia-Pavia, P. (2022). Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC: CardioOncology, 4(4), 442–454. https://doi.org/10.1016/j.jaccao.2022.07.007
Publication Date
Rosanoff, A., West, C., Elin, R. J., Micke, O., Baniasadi, S., Barbagallo, M., Campbell, E., Cheng, F.-C., Costello, R. B., Gamboa-Gomez, C., Guerrero-Romero, F., Gletsu-Miller, N., von Ehrlich, B., Iotti, S., Kahe, K., Kim, D. J., Kisters, K., Kolisek, M., … Kraus, A. (2022). Recommendation on an updated standardization of serum magnesium reference ranges. European Journal of Nutrition, 61(7), 3697–3706. https://doi.org/10.1007/s00394-022-02916-w
Publication Date
Westin, O. M., Butt, J. H., Gustafsson, F., Køber, L., Vinther, M., Maurer, M. S., & Fosbøl, E. L. (2022). Carpal Tunnel Syndrome in Patients Who Underwent Pacemaker Implantation and Relation to Amyloidosis, Heart Failure, and Mortality. The American Journal of Cardiology, 177, 121–127. https://doi.org/10.1016/j.amjcard.2022.04.059
Publication Date
Vilches, S., Fontana, M., Gonzalez‐Lopez, E., Mitrani, L., Saturi, G., Renju, M., Griffin, J. M., Caponetti, A., Gnanasampanthan, S., De los Santos, J., Gagliardi, C., Rivas, A., Dominguez, F., Longhi, S., Rapezzi, C., Maurer, M. S., Gillmore, J., & Garcia‐Pavia, P. (2022). Systemic embolism in amyloid transthyretin cardiomyopathy. European Journal of Heart Failure, 24(8), 1387–1396. Portico. https://doi.org/10.1002/ejhf.2566
Publication Date
Cuddy, S. A. M., Jerosch-Herold, M., Falk, R. H., Kijewski, M. F., Singh, V., Ruberg, F. L., Sanchorawala, V., Landau, H., Maurer, M. S., Yee, A. J., Bianchi, G., Di Carli, M. F., Liao, R., Kwong, R. Y., & Dorbala, S. (2022). Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy. JACC: Cardiovascular Imaging, 15(4), 594–603. https://doi.org/10.1016/j.jcmg.2021.09.032
Publication Date
Stewart, L. A., Steinl, G. K., Huang, B. L., McManus, C., Lee, J. A., Kuo, J. H., & Walker, M. D. (2021). Primary Hyperparathyroidism Is Associated With Shorter QTc Intervals, but Not Arrhythmia. The Journal of Clinical Endocrinology & Metabolism, 107(4), e1689–e1698. https://doi.org/10.1210/clinem/dgab820
Publication Date
Bhogal, S., Garcia-Garcia, H. M., Klein, A., Benzuly, K., Mangalmurti, S., Moses, J., Alaswad, K., Jaffer, F., Yong, C., Nanjundappa, A., Ben-Dor, I., Mintz, G. S., Hashim, H., & Waksman, R. (2022). CRT-100.04 Intravascular Lithotripsy for the Treatment of Severely Calcified Coronary Artery Disease: An IVUS Sub-Study. JACC: Cardiovascular Interventions, 15(4), S1. https://doi.org/10.1016/j.jcin.2022.01.073
Publication Date
Bhattacharya, P. T., Fox, A. N., Marboe, C. C., Lagana, S. M., Remotti, H. E., D’Armiento, J. M., Goldklang, M. P., Eisenberger, A. B., Griffin, J. M., & Maurer, M. S. (2021). Can lightning strike twice? Wild-type transthyretin cardiac amyloidosis associated with rare liver disease. Oxford Medical Case Reports, 2021(11–12). https://doi.org/10.1093/omcr/omab113
Publication Date
Zander, D., Bunch, P. M., Policeni, B., Juliano, A. F., Carneiro-Pla, D., Dubey, P., Gule-Monroe, M. K., Hagiwara, M., Hoang, J. K., Jain, V., Kim, L. T., Moonis, G., Parsons, M. S., Rath, T. J., Solórzano, C. C., Subramaniam, R. M., Taheri, M. R., DuChene Thoma, K., Trout, A. T., … Corey, A. S. (2021). ACR Appropriateness Criteria® Parathyroid Adenoma. Journal of the American College of Radiology, 18(11), S406–S422. https://doi.org/10.1016/j.jacr.2021.08.013
Publication Date
Muchtar, E., Wisniowski, B., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Dispenzieri, A., Kumar, S., Leung, N., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Witteles, R., Sanchorawala, V., Szalat, R., Landau, H. J., Petrlik, E., … Gertz, M. A. (2021). Graded Renal Response Criteria for Light Chain (AL) Amyloidosis. Blood, 138(Supplement 1), 2721–2721. https://doi.org/10.1182/blood-2021-149594
Publication Date
Hopson, M., Bhutani, D., Sarkaria, S. M., Maurer, M., Griffin, J., Lentzsch, S., & Chakraborty, R. (2021). Impact of Light Chain Isotype on Clinical Features and Outcomes in Systemic AL Amyloidosis. Blood, 138(Supplement 1), 4726–4726. https://doi.org/10.1182/blood-2021-149299
Publication Date
Muchtar, E., Dispenzieri, A., Wisniowski, B., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Kumar, S., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Witteles, R., Sanchorawala, V., Szalat, R., Landau, H. J., Petrlik, E., Lentzsch, S., … Gertz, M. A. (2021). Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival. Blood, 138(Supplement 1), 2720–2720. https://doi.org/10.1182/blood-2021-149222
Publication Date
Westin, O., Butt, J. H., Gustafsson, F., Schou, M., Salomo, M., Køber, L., Maurer, M., & Fosbøl, E. L. (2021). Two Decades of Cardiac Amyloidosis. JACC: CardioOncology, 3(4), 522–533. https://doi.org/10.1016/j.jaccao.2021.05.004
Publication Date
Fusaro, M., Tripepi, G., Plebani, M., Politi, C., Aghi, A., Taddei, F., Schileo, E., Zaninotto, M., La Manna, G., Cianciolo, G., Gallieni, M., Cosmai, L., Messa, P., Ravera, M., Nickolas, T. L., Ferrari, S., Ketteler, M., Iervasi, G., Mereu, M. C., … De Caterina, R. (2021). The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study. Nutrients, 13(10), 3567. https://doi.org/10.3390/nu13103567
Publication Date
Whelan, C., Coelho, T., Conceicao, I., Brannagan Iii, T. H., Wang, A. K., Polydefkis, M. J., Dyck, P. J., Berk, J. L., Obici, L., Kristen, A., Narayana, A., Olugemo, K., Aquino, P., Benson, M. D., & Gertz, M. (2021). Long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloid polyneuropathy with or without cardiomyopathy: post hoc analysis of NEURO-TTR open-label extension. European Heart Journal, 42(Supplement_1). https://doi.org/10.1093/eurheartj/ehab724.2745
Publication Date